The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans
Abstract
Inhibition of the activity of the human bile salt export pump (BSEP: ABCB11) has been proposed to play a role in drug-induced liver injury (DILI). To enhance understanding of the relationship between BSEP inhibition and DILI, inhibition of human BSEP (hBSEP) and its rat ortholog (rBsep) by 85 pharmaceuticals was investigated in vitro. This was explored using assays that quantified inhibition of ATP-dependent [(3)H]taurocholate uptake into inverted plasma membrane vesicles from Sf21 insect cells, which expressed the proteins. Of the pharmaceuticals, 40 exhibited evidence of in vitro transporter inhibition and overall a close correlation was observed between potency values for inhibition of hBSEP and rBsep activity (r(2) = 0.94), although 12 drugs exhibited >2-fold more potent inhibition of hBSEP than rBsep. The median potency of hBSEP inhibition was higher among drugs that caused cholestatic/mixed DILI than among drugs that caused hepatocellular or no DILI, as was the incidence of hBSEP inhibition with IC(50) <300 μM. All drugs with hBSEP IC(50) <300 μM had molecular weight >250, ClogP >1.5, and nonpolar surface area >180Å. A clear distinction was not evident between hBSEP IC(50) or unbound plasma concentration (C(max, u)) of the drugs in humans and whether the drugs caused DILI. However, all 17 of the drugs with hBSEP IC(50) <100 μM and C(max, u) >0.002 μM caused DILI. Overall, these data indicate that inhibition of hBSEP/rBsep correlates with the propensity of numerous pharmaceuticals to cause cholestatic DILI in humans and is associated with several of their physicochemical properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Strautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E., Dahan, K., Childs, S., Ling, V., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 995
Bile-acid-induced cell injury and protection
Perez, M. J., & Briz, O. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1677 · Cited by 717
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 582
Hepatotoxicity the adverse effects of drugs and other chemicals on the liver
Zimmerman, H. J. (1999) · Cited by 514
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Abboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 479
Fickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H., Krause, R., Lammert, F., Langner, C., Zatloukal, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.009 · Cited by 468
Kartenbeck, J., Leuschner, U., Mayer, R., & Keppler, D. (1996) · Hepatology · doi:10.1002/hep.510230519 · Cited by 398
Cited by
Items 301–349 of 349
Kenna, J. G., Stahl, S. H., & Noeske, T. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_30
Self-citationKöck, K., Ferslew, B. C., Netterberg, I., Yang, K., Urban, T. J., Swaan, P. W., Stewart, P. W., & Brouwer, K. L. R. (2014)
Two Liver Transporters, ABCB11 and ABCC6; Novel Therapeutic Approaches in the Related Disorders
Váradi, A., & Homolya, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-23476-2_15
Interaction of ABC Transporters with Drugs
Chiba, P., Ecker, G. F., Nasim, F., & Çakıl, Y. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-23476-2_7
Mechanisms of drug-induced liver injury: the role of hepatic transport proteins
Yang, K. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/tzn9-dw77
In-Vitro and In-Vivo Models of Bile Acid Metabolism and Transport
Thakare, R. N. (2017) · DigitalCommons@UNMC
Estudio de los fenómenos de autoinmunidad en la enfermedad hepática tóxica
Alonso, A. O. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Transporters in Hepatotoxicity
Kotsampasakou, E., Jain, S., Digles, D., & Ecker, G. F. (2018) · Computational Toxicology · doi:10.1002/9781119282594.ch6
Ferslew, B. C. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/7vmd-ss33
In silico prediction of drug-induced liver injury: Quo vadis?
Weng, C., & Leong, M. K. (2019) · Advances in molecular toxicology · doi:10.1016/b978-0-444-64293-6.00002-6
Davies, E. C. (2019) · Murdoch University Research Portal
The trends in predicting drug-induced liver injury
Takemura, A., & Ito, K. (2020) · Folia Pharmacologica Japonica · doi:10.1254/fpj.20049
Transporter, Drug Metabolism, and Drug‐Induced Liver Injury in Marketed Drugs
Chen, M., Ashby, K., & Wu, Y. (2021) · Wiley eBooks · doi:10.1002/9781119171003.ch2
Hepatic Bile Acid Transporters in Drug‐Induced Cholestasis
Hu, T., & Wang, H. (2021) · Wiley eBooks · doi:10.1002/9781119171003.ch10
Bile Salt Export Pump (BSEP) Inhibition
Treiber, A., & Bolli, M. H. (2021) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016414-00160
Albernaz, R. M., Araujo, R. A., Silva, M. H. M., Basile, R., Junior, W. H. F., Davanzo, E. F. A., Buzzolo, P. A., Rezende, T. G., Cavalheiro, A. M. A., & Queiroz-Neto, A. (2012) · Acervo Digital da Universidade Estadual Paulista (Universidade Estadual Paulista) · doi:10.1111/jvp.12007/abstract
Jungsuwadee, P., & Vore, M. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99186-4
Uzu, M., & Takezawa, T. (2025) · The Journal of Toxicological Sciences · doi:10.2131/jts.50.135
Idiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors
Stephens, C. M., Lucena, M. I., & Andrade, R. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00276-x
Jackson, J. P., & Brouwer, K. R. (2025) · Applied In Vitro Toxicology · doi:10.1177/23321539251399331
Additional file 1 of Cholangiocyte organoids to study drug-induced injury
Wang, Z., Xing, C., van der Laan, L. J. W., Verstegen, M. M. A., Spee, B., & Masereeuw, R. (2024) · Figshare · doi:10.6084/m9.figshare.25397460
Guo, C. (2018) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/z4sd-g830
Role of connexins and their channels in cholestasis
Cooreman, A. (2023) · VUBIR (Vrije Universiteit Brussel)
De rol van connexine en pannexine (hemi)kanalen in cholestase
Cooreman, A. (2023) · Lirias
サンドイッチ培養肝細胞を用いた薬物の肝胆系動態評価に関する研究
福田, 元., & Fukuda, H. (2013) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University)
Valentin, L. (2022) · theses.fr (ABES) · doi:10.70675/7d4d9dbaz2221z473ez8d83z615f5c28bdb7
Schieferdecker, S., Woelflingseder, L., & Lott, J. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00364
Stergiopoulos, C., & Valko, K. L. (2026) · ADMET & DMPK · doi:10.5599/admet.3303
Vignone, A., Montecalvo, D., Ferrari, P., Nardelli, S., Cola, S. D., d’Amati, G., Ascione, A., Corradini, S. G., Parisse, S., Ferri, F., et al. (2026) · ACG Case Reports Journal · doi:10.14309/crj.0000000000002162
Owczarzy, A., Piśla, P., Piordas, K., Rogóż, W., Kulig, K., Zięba, A., & Maciążek-Jurczyk, M. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1872215
In Vitro Three-Dimensional Human Liver Model for Drug-Induced Liver and Bile Duct Injury Prediction
Fu, X., Hu, J., Jiang, X., Sun, Y., Xiang, W., Kuang, R., Kang, H., He, L., & Sang, J. (2026) · Toxics · doi:10.3390/toxics14080724
Multitask learning in predictive toxicology: methods, benchmarks, and applications
Hong, H., Liu, J., Guo, W., & Patterson, T. A. (2026) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2026.2725245
栄一朗, 荻. (2018) · Institutional Repositories DataBase (IRDB) · doi:10.20776/105429
Soundharya, H., Pallavi, J., Naskar, R., Medishetti, R., Sedam, S. M., Chatti, K., Parsa, K. V. L., & Chakraborty, S. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6c00322
New approach methodologies for in vitro detection of chemical-induced cholestatic liver injury
Maerten, A., Avîrvarei, A.-C., & Vinken, M. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04541-6
Cao, M., Duan, X., Li, J., Zhou, Z., & Jin, H. (2026) · Future Integrative Medicine · doi:10.14218/fim.2026.00017
TechBio 3.0 closes the drug discovery loop with multimodal AI and generative chemistry
Ramadurai, K. W., & Banerjee, A. (2026) · npj Drug Discovery. · doi:10.1038/s44386-026-00078-x
DRUG-INDUCED LIVER INJURY: MECHANISMS, BIOMARKERS AND CAUSALITY ASSESSMENT
Kaczmarek, L., Dubois, L., & Claes, M. (2022) · Pharma research · doi:10.62655/s-epub.2022.v14.i02.pp51-58
BindingDB (2020) · UC San Diego · doi:10.7270/q29c70zd
BindingDB Entry 50014961: Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA
BindingDB (2023) · UC San Diego · doi:10.7270/q2pz5dp9
Park, C., Oh, H., Jang, C., & Kim, T. H. (2026) · Antioxidants · doi:10.3390/antiox15111410
Cuba, L., HASSLINGER, S., Plieger, M., Zaekova, A., & Ferlitsch, M. (2026) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-026-01200-4
Metadata
- Authors
- Dawson, S., Stahl, S., Paul, N., Barber, J., & Kenna, J. G.
- Affiliations
- AstraZeneca (United Kingdom) (GB)
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 40
- Issue
- 1
- Pages
- 130-138
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2134837921
- Semantic Scholar
- 60ba71aac3cdfdcd69699825099b32f2949b1f89
- Cited by
- 343
- References
- 49
- Citations by year
- 2026: 18 · 2025: 13 · 2024: 10 · 2023: 9 · 2022: 20 · 2021: 16 · 2020: 20 · 2019: 25 · 2018: 25 · 2017: 43 · 2016: 40 · 2015: 27 · 2014: 28 · 2013: 35 · 2012: 13
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Drug Metabolism and Disposition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- bile salt export pump, ABCB11, drug-induced liver injury, cholestatic liver injury, transporter inhibition, taurocholate uptake, physicochemical properties, drug safety prediction, hepatotoxicity
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily B, Member 11, Animals, Bile Acids and Salts, Cell Line, Cholestasis, Humans, Insecta, Risk Factors, ATP-Binding Cassette Transporters, Rats, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.